[
  {
    "ts": "2025-12-22T08:58:00+00:00",
    "headline": "Should You Forget Novo Nordisk and Buy This Magnificent High-Yield Drug Stock Instead?",
    "summary": "Novo Nordisk gained a head start in the GLP-1 race but then fell behind; Pfizer is working hard to catch up to the new leader.",
    "url": "https://www.fool.com/investing/2025/12/22/forget-novo-nordisk-buy-high-yield-drug-stock/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "2c160554-0225-3523-ac6e-41ac27dc9837",
      "content": {
        "id": "2c160554-0225-3523-ac6e-41ac27dc9837",
        "contentType": "STORY",
        "title": "Should You Forget Novo Nordisk and Buy This Magnificent High-Yield Drug Stock Instead?",
        "description": "",
        "summary": "Novo Nordisk gained a head start in the GLP-1 race but then fell behind; Pfizer is working hard to catch up to the new leader.",
        "pubDate": "2025-12-22T08:58:00Z",
        "displayTime": "2025-12-22T08:58:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/34be29d992e20b626208f7610cd6ad29",
          "originalWidth": 1200,
          "originalHeight": 801,
          "caption": "A medical professional filling a needle from a bottle of medicine.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4FLKocTE8Dy4an3gq.W46A--~B/aD04MDE7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/34be29d992e20b626208f7610cd6ad29.cf.webp",
              "width": 1200,
              "height": 801,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OjZI_UgWLI8P7SE8GyR7Cw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/34be29d992e20b626208f7610cd6ad29.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/12/22/forget-novo-nordisk-buy-high-yield-drug-stock/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/forget-novo-nordisk-buy-magnificent-085800517.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-22T09:59:07+00:00",
    "headline": "Abivax soars on report of Eli Lilly meeting French officials over possible deal",
    "summary": "Investing.com -- Abivax shares jumped after fresh media reports revived speculation that U.S. drugmaker Eli Lilly is exploring a takeover of the French biotech company.",
    "url": "https://finance.yahoo.com/news/abivax-soars-report-eli-lilly-095907134.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "0b3c9723-f11f-35e7-b056-b8543a20195a",
      "content": {
        "id": "0b3c9723-f11f-35e7-b056-b8543a20195a",
        "contentType": "STORY",
        "title": "Abivax soars on report of Eli Lilly meeting French officials over possible deal",
        "description": "",
        "summary": "Investing.com -- Abivax shares jumped after fresh media reports revived speculation that U.S. drugmaker Eli Lilly is exploring a takeover of the French biotech company.",
        "pubDate": "2025-12-22T09:59:07Z",
        "displayTime": "2025-12-22T09:59:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abivax-soars-report-eli-lilly-095907134.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abivax-soars-report-eli-lilly-095907134.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AAVXF"
            },
            {
              "symbol": "ABVX"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "ADVM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]